RPRX
Royalty Pharma plcWhen RPRX passed all Ten ChecksRoyalty Pharma plc
history · not a forecastOver the past 10 years, RPRX has passed all Ten Checks on 9 separate days. Here is how it moved over the 20 trading sessions that followed — how far it rose, and how far it fell.
The strongest of them rose +7.9% in Jan 2021, peaked day 14.
- Apr 2026+5.9% +0.0%
- Apr 2025+3.3% -1.9%
- Mar 2025+2.2% -6.6%
Peak and dip mark the highest and lowest closing prices over those 20 sessions; the intraday swings ran wider still, and neither figure is a return you could have captured by buying and selling at the perfect moment. These are historical readings from the past 10 years, drawn only from the US-listed stocks the site covers today — a record of what happened, not a prediction of what will, and not investment advice.
6-month history — checks vs. price
Price on the left axis; checks passing (0–10) on the right.
Common questions about RPRX’s checks
How many technical checks does RPRX pass right now?
As of the Oct 2, 2026 close, RPRX passes 5 of 10 fixed technical checks — the checks not passing: holding above short-term average, no recent earnings miss, outperforming the market, stop distance within range, adequate stop room.
Why does RPRX fail the "holding above short-term average" check?
RPRX closed at $57.16, 1.5% below its 9-day average ($58.06), so this momentum check fails. It passes again on a close above $58.06.
What price would change RPRX's check count?
The nearest flip level is "adequate stop room" passes on a close above $58.02. Each price-anchored check has an exact next-close level, shown in the Flip levels panel above.
Factual measurements from the latest scan — not investment advice.